Drax Group (DRX) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
2 Feb, 2026Executive summary
Achieved strong operational and financial performance in H1 2024, with adjusted EBITDA up 24% to £515m, driven by renewables, pellet production, and Energy Solutions.
Increased dividend per share by 12.6% to 10.4p, with a full-year expectation of 26.0p/share.
Announced a £300 million two-year share buyback program commencing Q3 2024.
Strengthened balance sheet with over £680 million in new facilities, repaid £949 million of shorter-dated maturities, and reduced net debt to £1,035m.
Reduced safety incidents by 49% year-over-year (TRIR 0.24 vs. 0.47).
Financial highlights
Adjusted EBITDA rose to £515m (H1 2023: £417m), with adjusted basic EPS at 65.6p (H1 2023: 46.0p).
Cash generated from operations was £400m, broadly in line with the prior period.
Net debt to Adjusted EBITDA: 0.9x, well below the long-term target of 2x.
Interim dividend of 10.4p/share, with a full-year expectation of 26.0p/share.
Capital expenditure in H1 2024 totaled £147m, focused on OCGT projects, pellet plant expansion, and enhancement projects.
Outlook and guidance
Full-year 2024 Adjusted EBITDA expected at the top end of analyst consensus (£961m, range £881–996m), subject to continued good operational performance.
Targeting >£500m recurring adjusted EBITDA post-2027 from FlexGen & Energy Solutions and Pellet Production.
Biomass generation expected to deliver >£1 billion operational cash flow between 2024-2027.
Ongoing discussions with UK Government on BECCS and bridging mechanism; clarity expected in H2 2024.
Latest events from Drax Group
- Record renewable output, robust cash flow, and major BESS investments drive 2025 strategy.DRX
H2 202526 Feb 2026 - Upgraded post-2027 EBITDA target, record financials, and robust outlook from renewables.DRX
H2 202417 Dec 2025 - 2025 Adj. EBITDA set to exceed expectations, supporting major growth and shareholder returns.DRX
Trading Update11 Dec 2025 - Strong H1-25 results, buyback extension, and new CfD terms boost long-term earnings outlook.DRX
H1 202531 Jul 2025 - Strong 2024 performance, strategic growth in BECCS and renewables, and robust capital returns.DRX
Trading Update13 Jun 2025 - Drax expects 2025 Adj. EBITDA at the top end of consensus, driven by strong operations and contracts.DRX
Q1 20256 Jun 2025 - Drax forecasts top-end 2025 Adj. EBITDA, advances flexible generation, and boosts shareholder returns.DRX
Trading Update6 Jun 2025